An observational study in Residents in Longterm Care Facilities, sponsored by Centre hospitalier de l'Université de Montréal (CHUM). Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2023-09-13.
Sponsored by Centre hospitalier de l'Université de Montréal (CHUM) · Observational
The acronym for this proposal, BABEL, refers to the fact that a common "language" - the interRAI risk-stratification and decision-making tool - will be used in this project, allowing several measures of care quality in long-term care facilities to be compared with those in other provinces for the first time. The impact of the use of this assessment system and associated care planning protocols will also be investigated using usual practice as the point of reference.
Centre hospitalier de l'Université de Montréal (CHUM) is the lead sponsor of 370 studies on the registry; 110 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Residents in a long-term care facility (nursing home)
Exclusion Criteria:
Nursing homes in Quebec where interRAI evaluations and care plans will be introduced.
Other: interRAI LTCF
Standardized evaluations (interRAI LTCF) will be introduced to selected nursing homes in Quebec.
Change in depression prevalence
Depression rating scale score of 3 or more (from interRAI LTCF)
Time frame: Every 3 months, for a minimum of 6 months and a maximum of 36 months
Change in prevalence of potentially inappropriate antipsychotic use
Use of antipsychotics in the absence of an appropriate diagnosis
Time frame: Every 3 months, for a minimum of 6 months and a maximum of 36 months
Change in falls prevalence
Prevalence of falls among residents under study
Time frame: Every 3 months, for a minimum of 6 months and a maximum of 36 months
Change in prevalence of pain
Using interRAI pain scale scores greater than 0
Time frame: Every 3 months, for a minimum of 6 months and a maximum of 36 months
Change in the prevalence of physical restraints use
Use of physical restraints on residents as assessed using interRAI LTCF
Time frame: Every 3 months, for a minimum of 6 months and a maximum of 36 months
Change in prevalence of pressure ulcers
Stage 2 pressure ulcer on the interRAI pressure ulcer scale
Time frame: Every 3 months, for a minimum of 6 months and a maximum of 36 months
Change in other interRAI LTCF quality indicators
interRAI LTCF evaluation leads to a number of quality indicators being generated each of which will be tracked over time for each facility to compare before and after effects, as well as comparisons with other centers in Canada
Time frame: Every 3 months, for a minimum of 6 months and a maximum of 36 months
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre hospitalier de l'Université de Montréal (CHUM)